October 24, 2014 7:20 AM ET


Company Overview of Oxagen Limited

Executive Profile

John Irving Bell

Founder, Chairman of Development Advisory Board and Deputy Chairman, Oxagen Limited
AgeTotal Calculated CompensationThis person is connected to 7 Board Members in 7 different organizations across 6 different industries.

See Board Relationships


Dr. John Irving Bell, MA, DM, FRCP is the Founder of Oxagen Limited. Dr. Bell co-founded Wellcome Trust Centre for Human Genetics at the University of Oxford. He serves as Development Advisory Board Chairman of Oxagen Limited. He serves as Deputy Chairman and Director of Oxagen Limited. He serves as a Director of Isis Innovation Limited. He serves as a Main Board Member of Roche AG. He serves as a Trustee of The Rhodes Trust. He serves as a Member of Scientific Advisory ...

Corporate Headquarters

99 Park Drive
Abingdon, Oxfordshire OX14 4RY

United Kingdom

Phone: 44 12 3584 1561
Fax: 44 1235 443301

Board Members Memberships

Founder, Chairman of Development Advisory Board and Deputy Chairman
Member of Partnership board
Former Non-executive Director
Director and Member of Audit Committee


Master's Degree
The Leland Stanford Junior University
Unknown/Other Education 1992
The Royal College of Physicians
Unknown/Other Education 1975
University Of Alberta
Unknown/Other Education 1979
Magdalen College
BA 1976
Magdalen College
MD 1990
Magdalen College

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Oxagen Limited, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.